Market Scope uses a multi-source methodology when preparing our annual and quarterly reports. We incorporate surgeon surveys, our extensive database of physicians and surgery centers, disease models, clinical studies, financial reports, and more. Our wide-ranging knowledge of products and technology and our comprehensive network of industry contacts also contribute to our coverage on the ophthalmic and orthopedic industries.
Knee arthroplasty is a major source of revenue for the orthopedic market. Global demand for knee procedures is rising alongside expanding elderly populations and increased access to care in historically underserved countries. New technology and innovative implant designs promise to shift the cost-benefit ratio of the procedures, which coincides with pressure from global health care system to decrease costs. However, the COVID-19 pandemic will greatly impact the market landscape in 2020.
This report provides an in-depth analysis of the global knee arthroplasty market with forecasts through 2025. It is designed for manufacturers, providers, market analysts, and investors who are interested in the market and related products.
The United States Glaucoma Atlas provides a geographic analysis of the glaucoma population and treatment opportunity in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index™ Analysis analyzes market potential and provides a benchmark against other atlas metros. The Glaucoma Atlas offers strategic insights into the top potential markets in the US.
The 2020 Retinal Surgical Device Market Report provides in-depth analysis of the global retinal device market, examining the market’s size and growth, as well as identifying important developments that may shape its future. The analysis focuses on the 2020 market and forecasts market growth and evolution through 2025.
The 2020 Glaucoma Pharmaceuticals Market Report is Market Scope’s comprehensive analysis of the glaucoma pharmaceutical segment of ophthalmology. Our report is designed for members of the ophthalmic industry who participate in this market or are weighing doing so, market analysts, ophthalmologists who treat glaucoma patients, investors, and anyone else who might be interested in the global marketplace of glaucoma pharmaceuticals.
The interbody device market is estimated to be the largest segment of the overall spine surgery market. However, market share is expected to wane as alternatives to fusion improve and the cost of implants decreases.
Fusion procedure counts are expected to increase as the global population ages and access to medical care improves. Development of non-surgical and surgical alternatives such as artificial disc replacement will compete with these upward market trends. We estimate that the interbody device market will grow, but at a low single-digit CAGR.
This report is designed for manufacturers, market analysts, providers, and investors who are interested in the spine surgery business and interbody devices, specifically. The primary purpose of this report is to analyze the interbody device segment of the spine surgery market, identifying important trends and key factors for future success.
Hip arthroplasty—including primary THA, revision THA, and hemiarthroplasty—is a major revenue component of the orthopedic market. Global demand for these procedures is rising alongside expanding elderly population segments and increased access to care in historically underserved countries. New technology and innovative implant designs promise to shift the cost-benefit ratio of the procedures, which coincides with pressure from global health care system to decrease costs.
This report provides an in-depth analysis of the global hip arthroplasty market with forecasts through 2024. It is designed for manufacturers, providers, market analysts, and investors who are interested in the hip arthroplasty market and related products.
This report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market. The information covers investments in ophthalmic ventures in 2018 and the first 10 months of 2019, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings.
The primary purpose of this report is to analyze investments in ophthalmology and provide information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures.
Market Scope estimates strong growth in the artificial disc replacement (ADR) market over the next five years due to increased payer coverage and surgeon adoption in the US and Europe. Our 2019 Artificial Disc Replacement Market Report provides contextual information for understanding ADR market opportunity, and it forecasts market growth over the next five years. The report is designed for spine industry manufacturers, market analysts, providers, and investors who are interested in the artificial disc business.
Surgical robots are poised to disrupt the spine, knee, and hip surgery markets by improving results, reducing complications, and lowering overall costs. Surgical robots also offer the opportunity to sell robot-advantaged implants; we expect that early entrants to this market will have long-term advantages.
Our 2019 Orthopedic Surgical Robot Market Report identifies important trends and drivers for future success with a focus on the 2019 market and forecasts for market growth over the next five years. The report is designed for orthopedic robot and implant manufacturers, orthopedic providers, market analysts, and investors who are interested in the surgical robot market and related products.
Market Scope’s 2019 Spine Biologics Market Report provides in-depth coverage of the market, identifying important trends and key factors for future success. Our analysis includes market data for 2018 and forecasts performance through 2024.
This report is designed for spine industry manufacturers, market analysts, providers, and investors who are interested in the spine biologics business and related products. In-depth topics include prospective patients, surgeons, hospitals, and manufacturers of both naturally derived and synthetically produced biologics.
A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.